Pain-Relief Medication
PreclinicalSmall molecule
Pain-Relief Medication is one of 21 small molecule programs targeting Rotator Cuff Tear. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
20
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
23 competitors in Rotator Cuff Tear
#DrugCompanyPhaseTrials
1Tylenol
KKenvue Brands
Approved
Marcaine
IInnocoll
Approved
Ultram
WWim Janssens
Approved
Decadron
AAspen Global Incorporated
Approved
Depo-Testosterone
AAzurity Pharmaceuticals
Approved
Neurontin
VViatris Specialty LLC
Approved
Valium
Akero TherapeuticsApproved
Celebrex
PPhiladelphia Eye Associates
Approved
Suboxone
IIndivior Inc.
Approved
IC-Green
PProvepharm SAS
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Pain-Relief Medication. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- PParc de Salut Mar